176 related articles for article (PubMed ID: 16859500)
1. Breast cancer prognosis by combinatorial analysis of gene expression data.
Alexe G; Alexe S; Axelrod DE; Bonates TO; Lozina II; Reiss M; Hammer PL
Breast Cancer Res; 2006; 8(4):R41. PubMed ID: 16859500
[TBL] [Abstract][Full Text] [Related]
2. Logical analysis of diffuse large B-cell lymphomas.
Alexe G; Alexe S; Axelrod DE; Hammer PL; Weissmann D
Artif Intell Med; 2005 Jul; 34(3):235-67. PubMed ID: 16023562
[TBL] [Abstract][Full Text] [Related]
3. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
4. A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.
Jiang D; Zhao N
J Cancer Res Clin Oncol; 2006 Sep; 132(9):579-87. PubMed ID: 16761122
[TBL] [Abstract][Full Text] [Related]
5. Pseudogene-gene functional networks are prognostic of patient survival in breast cancer.
Smerekanych S; Johnson TS; Huang K; Zhang Y
BMC Med Genomics; 2020 Apr; 13(Suppl 5):51. PubMed ID: 32241256
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
7. Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Karlsson E; Delle U; Danielsson A; Olsson B; Abel F; Karlsson P; Helou K
BMC Cancer; 2008 Sep; 8():254. PubMed ID: 18778486
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.
Smith DD; Saetrom P; Snøve O; Lundberg C; Rivas GE; Glackin C; Larson GP
BMC Bioinformatics; 2008 Jan; 9():63. PubMed ID: 18226260
[TBL] [Abstract][Full Text] [Related]
9. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
10. The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
Milioli HH; Vimieiro R; Riveros C; Tishchenko I; Berretta R; Moscato P
PLoS One; 2015; 10(7):e0129711. PubMed ID: 26132585
[TBL] [Abstract][Full Text] [Related]
11. Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes.
Tsumagari K; Chijiiwa K; Nagai H; Makita M; Kasumi F; Akiyama F; Sakamoto G; Miki Y
Breast Cancer; 2005; 12(3):166-77. PubMed ID: 16110286
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Langerød A; Zhao H; Borgan Ø; Nesland JM; Bukholm IR; Ikdahl T; Kåresen R; Børresen-Dale AL; Jeffrey SS
Breast Cancer Res; 2007; 9(3):R30. PubMed ID: 17504517
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
14. Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
Guo L; Mao L; Lu W; Yang J
Biosystems; 2021 Jan; 199():104317. PubMed ID: 33279569
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factor analysis for breast cancer using gene expression profiles.
Joe S; Nam H
BMC Med Inform Decis Mak; 2016 Jul; 16 Suppl 1(Suppl 1):56. PubMed ID: 27454576
[TBL] [Abstract][Full Text] [Related]
16. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context.
Abraham G; Kowalczyk A; Loi S; Haviv I; Zobel J
BMC Bioinformatics; 2010 May; 11():277. PubMed ID: 20500821
[TBL] [Abstract][Full Text] [Related]
17. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
[TBL] [Abstract][Full Text] [Related]
18. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
19. Predictors of breast cancer cell types and their prognostic power in breast cancer patients.
Wang F; Dohogne Z; Yang J; Liu Y; Soibam B
BMC Genomics; 2018 Feb; 19(1):137. PubMed ID: 29433432
[TBL] [Abstract][Full Text] [Related]
20. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
